Newsroom

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/8/2026 Issue ¦ Oban Cards 2021-1 Plc - Class D GBP 219,754,000 FRN due January 2026     ISIN Number ¦ XS2274100861 ISIN Reference ¦ 227410086 Issue Nomin GBP ¦ 219754000 Period ¦ 12/15/2025 to 1/15/2026   Payment Date 1/15/2026 Number of Days ¦ 31 Rate ¦ 3.8435   Denomination GBP ¦ 1000   ¦ 219754000   ¦       Amount Payable per Denomination ¦ 3.26   ¦ 717352.31   ¦       Bank of New York     Rate...

ANNAPOLIS, Md.--(BUSINESS WIRE)--A top-line view of distinct opportunities for feline health across the veterinary profession, and for cats across the entire pet health industry....

DUBLIN--(BUSINESS WIRE)--The "Meat and Poultry Market in France: Business Report 2025" report has been added to ResearchAndMarkets.com's offering. The report presents analysis of the meat and poultry market in France. Scope Brief country profile includes general information and main economic indicators and specifies business environment in France Meat and Poultry market is analyzed by different parameters including domestic production and consumption. Future market development is also estimated...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/8/2026 Issue ¦ Oban Cards 2021-1 Plc - Class A GBP 233,346,000 FRN due January 2026     ISIN Number ¦ XS2274099832 ISIN Reference ¦ 227409983 Issue Nomin GBP ¦ 233346000 Period ¦ 12/15/2025 to 1/15/2026   Payment Date 1/15/2026 Number of Days ¦ 31 Rate ¦ 5.3935   Denomination GBP ¦ 1000   ¦ 233346000   ¦       Amount Payable per Denomination ¦ 4.58   ¦ 1068906.88   ¦       Bank of New York     Rat...

DUBLIN--(BUSINESS WIRE)--The "GLP-1 Market: Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering. The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to USD 157.5 billion by 2035, at a CAGR of 9.7% during the forecast period, till 2035. The efficacy of GLP-1 medications in weight management presents opportunities for wider application in non-diabetic groups, combating the worldwide obesity crisis. Improvem...

LINKÖPING, Zweden--(BUSINESS WIRE)--AMRA Medical, wereldwijd leider in MRI-gebaseerde analyse van vetverdeling en spiersamenstelling, en Prescan, een vooraanstaande Nederlandse aanbieder van preventieve gezondheidszorg, kondigen met trots de officiële lancering aan van hun geavanceerde AMRA® BCP Scan-service, aangedreven door AMRA® Profiler (CE, NB 2862), in Nederland. Deze lancering, de derde nieuwe marktintroductie van BCP Scan in 2025 (na Zweden en Duitsland), breidt de beschikbaarheid van o...

LONDON--(BUSINESS WIRE)--  DB ETC plc COMPANY ANNOUNCEMENT Immediate Release 08 January 2026 Xtrackers Physical Gold ETC (EUR) (Incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Buy-Back of ETC Securities Announcement The Issuer has agreed to buy back the ETC Securities for the following Series as set out in the table below. Series Number of Securities to be bought back Trade Date Settlement Date ISIN Series 10 - Xtracker...

LINKÖPING, Suecia--(BUSINESS WIRE)--AMRA Medical, líder internacional en análisis de la distribución de grasa y composición muscular mediante resonancia magnética, junto con Prescan, líder holandés en atención sanitaria preventiva, tienen el placer de anunciar el lanzamiento oficial en los Países Bajos de su innovador servicio AMRA® BCP Scan, basado en AMRA® Profiler (CE, NB 2862). El lanzamiento, que supone la tercera entrada de BCP Scan en un nuevo mercado en 2025 (Suecia y Alemania), amplía...

PITTSBURGH--(BUSINESS WIRE)--Carnegie Learning, a global leader in AI-driven technology, curriculum, and professional learning solutions for K-12 education, announced today that the Florida State Board of Education has approved Carnegie Learning’s ¡Qué chévere! (Spanish 1–4) and T’es branché? (French 1–2) world language solutions for the 2025-2026 Florida K-12 World Languages Instructional Materials Adoption. Carnegie Learning was the only provider to be approved for all programs submitted. ¡Qu...

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biomunex Pharmaceuticals, a biopharmaceutical company specializing in the development of next generation immunotherapies based on the discovery and development of bispecific and multispecific antibodies, today announces its participation at the 11th Annual Oncology Innovation Forum, organized by Sachs Associates, on the 10th of January at the Marines’ Memorial Club in San Francisco (USA). The 2026 Oncology Innovation Forum programme is designed to disc...